NEJM Interview: Dr. Allison Goldfine on statins, the associated risk of diabetes, and the FDA's response.
Dr. Allison Goldfine is the head of the Section of Clinical Research at Joslin Diabetes Center and an associate professor of medicine at Harvard Medical School. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. A.B. Goldfine. Statins: Is It Really Time to Reassess Benefits and Risks? N Engl J Med 2012;366:1752-5.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.